Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Anti-Obesity Drugs Market, by Drug Type
1.4.2 North America Anti-Obesity Drugs Market, by Mechanism of Action
1.4.3 North America Anti-Obesity Drugs Market, by Route Of Administration
1.4.4 North America Anti-Obesity Drugs Market, by Distribution Channel
1.4.5 North America Anti-Obesity Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Anti-Obesity Drugs Market by Drug Type
3.1 North America Prescription Drugs Market by Country
3.2 North America Over The Counter Drugs Market by Country
Chapter 4. North America Anti-Obesity Drugs Market by Mechanism of Action
4.1 North America Centrally Acting Market by Country
4.2 North America Peripherally Acting Market by Country
Chapter 5. North America Anti-Obesity Drugs Market by Route Of Administration
5.1 North America Oral Route Market by Country
5.2 North America Subcutaneous Route Market by Country
Chapter 6. North America Anti-Obesity Drugs Market by Distribution Channel
6.1 North America Hospital Pharmacies Market by Country
6.2 North America Retail Pharmacies Market by Country
6.3 North America Online Pharmacies Market by Country
Chapter 7. North America Anti-Obesity Drugs Market by Country
7.1 US Anti-Obesity Drugs Market
7.1.1 US Anti-Obesity Drugs Market by Drug Type
7.1.2 US Anti-Obesity Drugs Market by Mechanism of Action
7.1.3 US Anti-Obesity Drugs Market by Route Of Administration
7.1.4 US Anti-Obesity Drugs Market by Distribution Channel
7.2 Canada Anti-Obesity Drugs Market
7.2.1 Canada Anti-Obesity Drugs Market by Drug Type
7.2.2 Canada Anti-Obesity Drugs Market by Mechanism of Action
7.2.3 Canada Anti-Obesity Drugs Market by Route Of Administration
7.2.4 Canada Anti-Obesity Drugs Market by Distribution Channel
7.3 Mexico Anti-Obesity Drugs Market
7.3.1 Mexico Anti-Obesity Drugs Market by Drug Type
7.3.2 Mexico Anti-Obesity Drugs Market by Mechanism of Action
7.3.3 Mexico Anti-Obesity Drugs Market by Route Of Administration
7.3.4 Mexico Anti-Obesity Drugs Market by Distribution Channel
7.4 Rest of North America Anti-Obesity Drugs Market
7.4.1 Rest of North America Anti-Obesity Drugs Market by Drug Type
7.4.2 Rest of North America Anti-Obesity Drugs Market by Mechanism of Action
7.4.3 Rest of North America Anti-Obesity Drugs Market by Route Of Administration
7.4.4 Rest of North America Anti-Obesity Drugs Market by Distribution Channel
Chapter 8. Company Profiles
8.1 Pfizer, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional & Segmental Analysis
8.1.4 Research & Development Expense
8.2 Boehringer Ingelheim International Gmbh
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional & Segmental Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Partnerships, Collaborations, and Agreements:
8.3 GlaxoSmithKline PLC (GSK)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.4 Novo Nordisk A/S
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental & Regional Analysis
8.4.4 Research & Development Expenses
8.4.5 Recent strategies and developments:
8.4.5.1 Approvals and Trials:
8.5 Rhythm Pharmaceuticals, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Research & Development Expenses
8.6 Gelesis Holdings Inc (PureTech Health)
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Research & Development Expenses
8.6.4 Recent strategies and developments:
8.6.4.1 Partnerships, Collaborations, and Agreements:
8.6.4.2 Approvals and Trials:
8.7 Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
8.7.1 Company Overview
8.7.2 Recent strategies and developments:
8.7.2.1 Acquisition and Mergers:
8.8 Vivus LLC
8.8.1 Company Overview
8.8.2 Recent strategies and developments:
8.8.2.1 Approvals and Trials:
8.9 CHEPLAPHARM Arzneimittel GmbH (Braun Beteiligungs GmbH)
8.9.1 Company Overview
8.10. KVK Tech, Inc.
8.10.1 Company Overview
Unique Offerings 